Inhibitory Effect of Omeprazole, a Specific Inhibitor of H

Yukio Fujino1, Keiko Mitsunaga2, Ikuo Yasumasu2

  • 1Department of Pharmacology, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo 173, Japan.

Insights

Omeprazole inhibits spicule formation in sea urchin embryos by blocking the H+ , K+ -ATPase proton pump, which is essential for calcium carbonate deposition required for skeletal development.

Area of Science:

  • Developmental Biology
  • Marine Biology
  • Biochemistry

Background:

  • Sea urchin embryos develop characteristic skeletal structures (spicules) composed of calcium carbonate.
  • The formation of these spicules involves complex cellular processes and ion transport mechanisms.
  • Proton pumps, such as H+ , K+ -ATPase, play critical roles in cellular ion homeostasis and metabolic reactions.

Purpose of the Study:

  • To investigate the effect of omeprazole, a specific H+ , K+ -ATPase inhibitor, on sea urchin embryo development, particularly spicule formation.
  • To determine the role of the H+ , K+ -ATPase proton pump in calcium carbonate deposition for spicule development.

Main Methods:

  • Sea urchin embryos (from mesenchyme blastula to pluteus stage) were cultured with omeprazole.
  • Micro-mere-derived cells were cultured with omeprazole at alkaline pH (8.2) to assess its effect on spicule rod formation.
  • Observed developmental abnormalities and cellular processes using microscopy.

Main Results:

  • Omeprazole treatment resulted in abnormal plutei with reduced spicule size and underdeveloped arms.
  • In cultured cells, omeprazole strongly inhibited spicule rod formation but did not affect pseudopodial cable outgrowth.
  • Omeprazole inhibited spicule formation even at alkaline pH, suggesting a localized acidification mechanism.

Conclusions:

  • The H+ , K+ -ATPase proton pump is indispensable for calcium carbonate deposition during spicule formation in sea urchin embryos.
  • Omeprazole's inhibition of spicule formation is likely due to the blocking of this essential proton pump.
  • The H+ pump may facilitate CaCO3 deposition by releasing H+ , driving the reaction forward, possibly through localized cell surface acidification.

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
475
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
523
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
7.0K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
407
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608